Publication: Analysis of Novel Mutations and Methylmalonyl-CoA Mutase Levels in Thai Patients with Isolated Methylmalonic Acidemia
Issued Date
2015-12-01
Resource Type
ISSN
15734927
00062928
00062928
Other identifier(s)
2-s2.0-84947047544
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Biochemical Genetics. Vol.53, No.11-12 (2015), 310-318
Suggested Citation
Phannee Sawangareetrakul, James R. Ketudat Cairns, Nithiwat Vatanavicharn, Somporn Liammongkolkul, Pornswan Wasant, Jisnuson Svasti, Voraratt Champattanachai Analysis of Novel Mutations and Methylmalonyl-CoA Mutase Levels in Thai Patients with Isolated Methylmalonic Acidemia. Biochemical Genetics. Vol.53, No.11-12 (2015), 310-318. doi:10.1007/s10528-015-9694-9 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/35065
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Analysis of Novel Mutations and Methylmalonyl-CoA Mutase Levels in Thai Patients with Isolated Methylmalonic Acidemia
Abstract
© 2015, Springer Science+Business Media New York. Isolated methylmalonic acidemia (MMA) is an autosomal recessive, inherited disorder that results from either a mut defect of the methylmalonyl-CoA mutase apoenzyme (MCM, the product of the MUT gene) or a cbl defect in the synthesis of its cofactor, adenosylcobalamin (AdoCbl). In this study, biochemical and mutational analyses of three patients clinically diagnosed with MMA were performed. No MCM activity was detected in leukocyte extracts of two patients, while high MCM activity was found in the other, suggesting mut0and cbl defects, respectively. A novel (c.IVS6 -3 to -8delCTTTTT, p.K444_L445insFC*) and two known mutations in the MUT gene and one novel (c.227_36delGACCCAAAGA, p.R76Mfs*14) mutation in the MMAB gene were identified. In addition, MCM immunoblot analysis of leukocyte extract samples of these three patients and eight patients previously reported by our group, as well as their parents, showed a good correlation between the MCM protein and activity levels. Patients with mut0defective subtypes lacked MCM activity and had no MCM band, while patients carrying the cbl defects had high MCM activity levels and an intense MCM band at about 83 kDa, in comparison to those in their parents. These data expand the mutation spectrum of MMA deficiency. In addition, the examination of MCM protein level may be used as an alternative technique to determine the mut0and cbl defective subgroups.